These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15126237)

  • 1. C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats.
    Stevens MJ; Zhang W; Li F; Sima AA
    Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E497-505. PubMed ID: 15126237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
    Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
    Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
    Sima AA; Zhang W; Sugimoto K; Henry D; Li Z; Wahren J; Grunberger G
    Diabetologia; 2001 Jul; 44(7):889-97. PubMed ID: 11508275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism.
    Cameron NE; Cotter MA
    Diabetes Metab Res Rev; 2002; 18(4):315-23. PubMed ID: 12203947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes.
    Kamiya H; Murakawa Y; Zhang W; Sima AA
    Diabetes Metab Res Rev; 2005; 21(5):448-58. PubMed ID: 15747389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats.
    Zhang W; Kamiya H; Ekberg K; Wahren J; Sima AA
    Diabetes Metab Res Rev; 2007 Jan; 23(1):63-70. PubMed ID: 16845685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of impaired insulin/IGF action in primary diabetic encephalopathy.
    Li ZG; Zhang W; Sima AA
    Brain Res; 2005 Mar; 1037(1-2):12-24. PubMed ID: 15777748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy.
    Sharma SS; Sayyed SG
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1022-8. PubMed ID: 17042909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
    Sayyed SG; Kumar A; Sharma SS
    Life Sci; 2006 Jul; 79(8):777-83. PubMed ID: 16581090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of diabetic polyneuropathy in type II diabetic BBZDR/Wor rats and in type I diabetic BB/Wor rats.
    Sima AA; Zhang W; Xu G; Sugimoto K; Guberski D; Yorek MA
    Diabetologia; 2000 Jun; 43(6):786-93. PubMed ID: 10907124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
    Cotter MA; Cameron NE; Hohman TC
    J Peripher Nerv Syst; 1998; 3(3):217-23. PubMed ID: 10959252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-Peptide reverses nociceptive neuropathy in type 1 diabetes.
    Kamiya H; Zhang W; Ekberg K; Wahren J; Sima AA
    Diabetes; 2006 Dec; 55(12):3581-7. PubMed ID: 17130507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes.
    Kamiya H; Zhang W; Sima AA
    Ann Neurol; 2004 Dec; 56(6):827-35. PubMed ID: 15497155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurocytokine, interleukin-6, corrects nerve dysfunction in experimental diabetes.
    Cameron NE; Cotter MA
    Exp Neurol; 2007 Sep; 207(1):23-9. PubMed ID: 17560573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats.
    Inkster ME; Cotter MA; Cameron NE
    Eur J Pharmacol; 2007 Apr; 561(1-3):63-71. PubMed ID: 17291486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
    Saini AK; Kumar H S A; Sharma SS
    Eur J Pharmacol; 2007 Jul; 568(1-3):164-72. PubMed ID: 17521626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats.
    Nangle MR; Gibson TM; Cotter MA; Cameron NE
    Planta Med; 2006 May; 72(6):494-500. PubMed ID: 16773532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effect of the Ca2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat.
    Kappelle AC; Biessels G; Bravenboer B; van Buren T; Traber J; de Wildt DJ; Gispen WH
    Br J Pharmacol; 1994 Mar; 111(3):887-93. PubMed ID: 8019766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition.
    Cotter MA; Ekberg K; Wahren J; Cameron NE
    Diabetes; 2003 Jul; 52(7):1812-7. PubMed ID: 12829651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
    Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.